This inventor holds 2 USPTO granted patents. Top assignee: Glaxosmithkline LLC. Active years: 2010-2012.
Company Filing History:
Years Active: 2010-2012
Title: Innovations of Qiaogong Su in Pharmaceutical Chemistry
Introduction
Qiaogong Su is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for treating diseases.
Latest Patents
Qiaogong Su holds 2 patents that focus on innovative pharmaceutical compositions. His latest patents include a crystalline form of topotecan monohydrochloride pentahydrate, which is designed to treat anti-viral and cancer-related diseases. The first patent discloses a novel crystalline form of this compound, along with corresponding pharmaceutical compositions and methods for its preparation and use. The second patent also details a similar crystalline form and its applications in treating various diseases.
Career Highlights
Qiaogong Su is currently employed at GlaxoSmithKline LLC, where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new treatment options for patients suffering from serious health conditions.
Collaborations
Throughout his career, Qiaogong Su has collaborated with esteemed colleagues, including Philip C Dell'Orco and Ann Marie Diederich. These collaborations have further enriched his research and contributed to the success of his innovative projects.
Conclusion
Qiaogong Su's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His patents and ongoing research continue to pave the way for new treatments that can improve patient outcomes.